The Experts below are selected from a list of 4545 Experts worldwide ranked by ideXlab platform
Costantino Romagnoli - One of the best experts on this subject based on the ideXlab platform.
-
Transcutaneous bilirubin measurement: Comparison of Respironics BiliCheck and JM-103 in a normal newborn population
Clinical biochemistry, 2012Co-Authors: Costantino Romagnoli, Enrico Zecca, Piero Catenazzi, Giovanni Barone, Antonio Alberto ZuppaAbstract:Abstract Objectives To compare the accuracy of BiliCheck™ (Respironics, Marietta, GA) and Konica-Minolta Air Shield JM-103 (Drager Medical Inc, Telford, PA) to evaluate total serum bilirubin (TSB). Methods Prospective blinded study comparing two diagnostic devices in 630 neonates requiring TSB measurement. Results Linear regression analysis showed a good correlation between BiliCheck™ and TSB ( r = 0.8212) as well as between JM-103 and TSB ( r = 0.8686). BiliCheck shows a tendency to underestimate TSB. The mean difference in TSB–TcB was − 1.4 mg/dL for BC (− 4.7/+ 1.8 mg/dL) and 0.3 mg/dL for JM-103 (− 2.6/+ 3.2 mg/dL). ROC analysis for TSB ≥ 12 mg/dL showed area under the curve for BiliCheck™ significantly lower than those for JM-103 ( p Conclusions In spite of similar diagnostic accuracy JM-103 could be preferred for some practical advantages, but its suitability in performing universal screening for severe hyperbilirubinemia deserves further investigations.
-
Attempt to improve transcutaneous bilirubinometry: a double-blind study of Medick BiliMed versus Respironics BiliCheck
Archives of Disease in Childhood-fetal and Neonatal Edition, 2007Co-Authors: D De Luca, Enrico Zecca, M Corsello, E Tiberi, Carla Maria Semeraro, Costantino RomagnoliAbstract:Objectives: To compare the accuracy of a new transcutaneous bilirubinometer, BiliMed (Medick SA, Paris, France) with BiliCheck (Respironics, Marietta, GA, USA), a widely available instrument, and with total serum bilirubin measurement. Design: A prospective double-blind study comparing the two devices was carried out. 686 healthy newborns needing measurement of their bilirubin were enrolled over a 4-month period. Serum and transcutaneous bilirubin measurements were taken with both devices within 15 minutes. The order of use of the instruments was randomised. Setting: Well-baby nursery ward in a university hospital, tertiary referral centre. Results: The linear regression analysis showed a better correlation between BiliCheck and serum bilirubin ( r = 0.75) than between BiliMed and serum bilirubin ( r = 0.45). BiliCheck variability (±2 SD of the mean bias from serum bilirubin) was within −87.2 to 63.3 μmol/l, while BiliMed variability was within −97.5 to 121.4 μmol/l. The receiver operating characteristic analysis (for serum bilirubin levels >205.2 μmol/l or >239.4 μmol/l) showed significantly higher areas under the curve for BiliCheck than those for BiliMed (p Conclusions: Despite the potential practical advantages of BiliMed, its reduced diagnostic accuracy in comparison with BiliCheck does not justify its use in clinical practice.
D De Luca - One of the best experts on this subject based on the ideXlab platform.
-
Attempt to improve transcutaneous bilirubinometry: a double-blind study of Medick BiliMed versus Respironics BiliCheck.
Archives of disease in childhood. Fetal and neonatal edition, 2007Co-Authors: D De Luca, E Zecca, M Corsello, E Tiberi, C Semeraro, C RomagnoliAbstract:To compare the accuracy of a new transcutaneous bilirubinometer, BiliMed (Medick SA, Paris, France) with BiliCheck (Respironics, Marietta, GA, USA), a widely available instrument, and with total serum bilirubin measurement. A prospective double-blind study comparing the two devices was carried out. 686 healthy newborns needing measurement of their bilirubin were enrolled over a 4-month period. Serum and transcutaneous bilirubin measurements were taken with both devices within 15 minutes. The order of use of the instruments was randomised. Well-baby nursery ward in a university hospital, tertiary referral centre. The linear regression analysis showed a better correlation between BiliCheck and serum bilirubin (r = 0.75) than between BiliMed and serum bilirubin (r = 0.45). BiliCheck variability (+/-2 SD of the mean bias from serum bilirubin) was within -87.2 to 63.3 micromol/l, while BiliMed variability was within -97.5 to 121.4 micromol/l. The receiver operating characteristic analysis (for serum bilirubin levels >205.2 micromol/l or >239.4 micromol/l) showed significantly higher areas under the curve for BiliCheck than those for BiliMed (p<0.001). Despite the potential practical advantages of BiliMed, its reduced diagnostic accuracy in comparison with BiliCheck does not justify its use in clinical practice.
-
Attempt to improve transcutaneous bilirubinometry: a double-blind study of Medick BiliMed versus Respironics BiliCheck
Archives of Disease in Childhood-fetal and Neonatal Edition, 2007Co-Authors: D De Luca, Enrico Zecca, M Corsello, E Tiberi, Carla Maria Semeraro, Costantino RomagnoliAbstract:Objectives: To compare the accuracy of a new transcutaneous bilirubinometer, BiliMed (Medick SA, Paris, France) with BiliCheck (Respironics, Marietta, GA, USA), a widely available instrument, and with total serum bilirubin measurement. Design: A prospective double-blind study comparing the two devices was carried out. 686 healthy newborns needing measurement of their bilirubin were enrolled over a 4-month period. Serum and transcutaneous bilirubin measurements were taken with both devices within 15 minutes. The order of use of the instruments was randomised. Setting: Well-baby nursery ward in a university hospital, tertiary referral centre. Results: The linear regression analysis showed a better correlation between BiliCheck and serum bilirubin ( r = 0.75) than between BiliMed and serum bilirubin ( r = 0.45). BiliCheck variability (±2 SD of the mean bias from serum bilirubin) was within −87.2 to 63.3 μmol/l, while BiliMed variability was within −97.5 to 121.4 μmol/l. The receiver operating characteristic analysis (for serum bilirubin levels >205.2 μmol/l or >239.4 μmol/l) showed significantly higher areas under the curve for BiliCheck than those for BiliMed (p Conclusions: Despite the potential practical advantages of BiliMed, its reduced diagnostic accuracy in comparison with BiliCheck does not justify its use in clinical practice.
C Romagnoli - One of the best experts on this subject based on the ideXlab platform.
-
Attempt to improve transcutaneous bilirubinometry: a double-blind study of Medick BiliMed versus Respironics BiliCheck.
Archives of disease in childhood. Fetal and neonatal edition, 2007Co-Authors: D De Luca, E Zecca, M Corsello, E Tiberi, C Semeraro, C RomagnoliAbstract:To compare the accuracy of a new transcutaneous bilirubinometer, BiliMed (Medick SA, Paris, France) with BiliCheck (Respironics, Marietta, GA, USA), a widely available instrument, and with total serum bilirubin measurement. A prospective double-blind study comparing the two devices was carried out. 686 healthy newborns needing measurement of their bilirubin were enrolled over a 4-month period. Serum and transcutaneous bilirubin measurements were taken with both devices within 15 minutes. The order of use of the instruments was randomised. Well-baby nursery ward in a university hospital, tertiary referral centre. The linear regression analysis showed a better correlation between BiliCheck and serum bilirubin (r = 0.75) than between BiliMed and serum bilirubin (r = 0.45). BiliCheck variability (+/-2 SD of the mean bias from serum bilirubin) was within -87.2 to 63.3 micromol/l, while BiliMed variability was within -97.5 to 121.4 micromol/l. The receiver operating characteristic analysis (for serum bilirubin levels >205.2 micromol/l or >239.4 micromol/l) showed significantly higher areas under the curve for BiliCheck than those for BiliMed (p<0.001). Despite the potential practical advantages of BiliMed, its reduced diagnostic accuracy in comparison with BiliCheck does not justify its use in clinical practice.
E Tiberi - One of the best experts on this subject based on the ideXlab platform.
-
Attempt to improve transcutaneous bilirubinometry: a double-blind study of Medick BiliMed versus Respironics BiliCheck.
Archives of disease in childhood. Fetal and neonatal edition, 2007Co-Authors: D De Luca, E Zecca, M Corsello, E Tiberi, C Semeraro, C RomagnoliAbstract:To compare the accuracy of a new transcutaneous bilirubinometer, BiliMed (Medick SA, Paris, France) with BiliCheck (Respironics, Marietta, GA, USA), a widely available instrument, and with total serum bilirubin measurement. A prospective double-blind study comparing the two devices was carried out. 686 healthy newborns needing measurement of their bilirubin were enrolled over a 4-month period. Serum and transcutaneous bilirubin measurements were taken with both devices within 15 minutes. The order of use of the instruments was randomised. Well-baby nursery ward in a university hospital, tertiary referral centre. The linear regression analysis showed a better correlation between BiliCheck and serum bilirubin (r = 0.75) than between BiliMed and serum bilirubin (r = 0.45). BiliCheck variability (+/-2 SD of the mean bias from serum bilirubin) was within -87.2 to 63.3 micromol/l, while BiliMed variability was within -97.5 to 121.4 micromol/l. The receiver operating characteristic analysis (for serum bilirubin levels >205.2 micromol/l or >239.4 micromol/l) showed significantly higher areas under the curve for BiliCheck than those for BiliMed (p<0.001). Despite the potential practical advantages of BiliMed, its reduced diagnostic accuracy in comparison with BiliCheck does not justify its use in clinical practice.
-
Attempt to improve transcutaneous bilirubinometry: a double-blind study of Medick BiliMed versus Respironics BiliCheck
Archives of Disease in Childhood-fetal and Neonatal Edition, 2007Co-Authors: D De Luca, Enrico Zecca, M Corsello, E Tiberi, Carla Maria Semeraro, Costantino RomagnoliAbstract:Objectives: To compare the accuracy of a new transcutaneous bilirubinometer, BiliMed (Medick SA, Paris, France) with BiliCheck (Respironics, Marietta, GA, USA), a widely available instrument, and with total serum bilirubin measurement. Design: A prospective double-blind study comparing the two devices was carried out. 686 healthy newborns needing measurement of their bilirubin were enrolled over a 4-month period. Serum and transcutaneous bilirubin measurements were taken with both devices within 15 minutes. The order of use of the instruments was randomised. Setting: Well-baby nursery ward in a university hospital, tertiary referral centre. Results: The linear regression analysis showed a better correlation between BiliCheck and serum bilirubin ( r = 0.75) than between BiliMed and serum bilirubin ( r = 0.45). BiliCheck variability (±2 SD of the mean bias from serum bilirubin) was within −87.2 to 63.3 μmol/l, while BiliMed variability was within −97.5 to 121.4 μmol/l. The receiver operating characteristic analysis (for serum bilirubin levels >205.2 μmol/l or >239.4 μmol/l) showed significantly higher areas under the curve for BiliCheck than those for BiliMed (p Conclusions: Despite the potential practical advantages of BiliMed, its reduced diagnostic accuracy in comparison with BiliCheck does not justify its use in clinical practice.
M Corsello - One of the best experts on this subject based on the ideXlab platform.
-
Attempt to improve transcutaneous bilirubinometry: a double-blind study of Medick BiliMed versus Respironics BiliCheck.
Archives of disease in childhood. Fetal and neonatal edition, 2007Co-Authors: D De Luca, E Zecca, M Corsello, E Tiberi, C Semeraro, C RomagnoliAbstract:To compare the accuracy of a new transcutaneous bilirubinometer, BiliMed (Medick SA, Paris, France) with BiliCheck (Respironics, Marietta, GA, USA), a widely available instrument, and with total serum bilirubin measurement. A prospective double-blind study comparing the two devices was carried out. 686 healthy newborns needing measurement of their bilirubin were enrolled over a 4-month period. Serum and transcutaneous bilirubin measurements were taken with both devices within 15 minutes. The order of use of the instruments was randomised. Well-baby nursery ward in a university hospital, tertiary referral centre. The linear regression analysis showed a better correlation between BiliCheck and serum bilirubin (r = 0.75) than between BiliMed and serum bilirubin (r = 0.45). BiliCheck variability (+/-2 SD of the mean bias from serum bilirubin) was within -87.2 to 63.3 micromol/l, while BiliMed variability was within -97.5 to 121.4 micromol/l. The receiver operating characteristic analysis (for serum bilirubin levels >205.2 micromol/l or >239.4 micromol/l) showed significantly higher areas under the curve for BiliCheck than those for BiliMed (p<0.001). Despite the potential practical advantages of BiliMed, its reduced diagnostic accuracy in comparison with BiliCheck does not justify its use in clinical practice.
-
Attempt to improve transcutaneous bilirubinometry: a double-blind study of Medick BiliMed versus Respironics BiliCheck
Archives of Disease in Childhood-fetal and Neonatal Edition, 2007Co-Authors: D De Luca, Enrico Zecca, M Corsello, E Tiberi, Carla Maria Semeraro, Costantino RomagnoliAbstract:Objectives: To compare the accuracy of a new transcutaneous bilirubinometer, BiliMed (Medick SA, Paris, France) with BiliCheck (Respironics, Marietta, GA, USA), a widely available instrument, and with total serum bilirubin measurement. Design: A prospective double-blind study comparing the two devices was carried out. 686 healthy newborns needing measurement of their bilirubin were enrolled over a 4-month period. Serum and transcutaneous bilirubin measurements were taken with both devices within 15 minutes. The order of use of the instruments was randomised. Setting: Well-baby nursery ward in a university hospital, tertiary referral centre. Results: The linear regression analysis showed a better correlation between BiliCheck and serum bilirubin ( r = 0.75) than between BiliMed and serum bilirubin ( r = 0.45). BiliCheck variability (±2 SD of the mean bias from serum bilirubin) was within −87.2 to 63.3 μmol/l, while BiliMed variability was within −97.5 to 121.4 μmol/l. The receiver operating characteristic analysis (for serum bilirubin levels >205.2 μmol/l or >239.4 μmol/l) showed significantly higher areas under the curve for BiliCheck than those for BiliMed (p Conclusions: Despite the potential practical advantages of BiliMed, its reduced diagnostic accuracy in comparison with BiliCheck does not justify its use in clinical practice.
